Pre-instillation of tumor microparticles enhances intravesical chemotherapy of nonmuscle-invasive bladder cancer through a lysosomal pathway. (January 2017)

• Record Type: Journal Article
• Authors: Jin, Xun; Ma, Jingwei; Liang, Xiaoyu; Tang, Ke; Liu, Yuying; Yin, Xiaonan; Zhang, Yi; Zhang, Huafeng; Xu, Pingwei; Chen, Degao; Zhang, Tianzhen; Lu, Jinzhi; Hu, Zhuowei; Qin, Xiaofeng; Zeng, Xiaoyong; Li, Longcheng; Huang, Bo
• Is Part Of: Biomaterials. Volume 113(2017)
• Page Start: 93
• Page End: 104
• Publication Date: 2017-01
• Subjects: Bladder cancer cell -- Microparticles -- Lysosomes -- Chemosensitizer -- Recurrence; Biomedical materials -- Periodicals; Biocompatible Materials -- Periodicals; Biomatériaux -- Périodiques; 610.28
• DOI: 10.1016/j.biomaterials.2016.10.036
• Languages: English
• ISSNs: 0142-9612

Abstract

Abstract: Nonmuscle-invasive bladder cancer (NMIBC) is treated with transurethral resection followed by intravesical chemotherapy. However, drug-resistant tumorigenic cells cannot be eliminated, leading to half of the treated cancers recur with increased stage and grade. Innovative approaches to enhance drug sensitivity and eradicate tumorigenic cells in NMIBC treatment are urgently needed. Here, we show that pre-instillation of tumor cell-derived microparticles (T-MP) as natural biomaterials markedly enhance the inhibitory effects of intravesical chemotherapy on growth and hematuria occurrence of orthotropic bladder cancer in mice. We provide evidence that T-MPs enter and increase the pH value of lysosomes from 4.6 to 5.6, leading to the migration of drug-loaded lysosomes along microtubule tracks toward the nucleus and discharging the drugs whereby for the entry of the nucleus. We propose that T-MPs may function as a potent sensitizer for augmenting NMIBC chemotherapy with unprecedented clinical benefits.